News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
359,264 Results
Type
Article (33485)
Company Profile (112)
Press Release (325667)
Section
Business (94916)
Career Advice (623)
Deals (14466)
Drug Delivery (56)
Drug Development (50581)
Employer Resources (57)
FDA (7774)
Job Trends (8271)
News (168854)
Policy (16646)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2026 Biotech Bay Standard (1)
Academia (2292)
Academic (1)
Accelerated approval (1)
Adcomms (17)
Allergies (24)
Alliances (28521)
ALS (41)
Alzheimer's disease (718)
Antibody-drug conjugate (ADC) (126)
Approvals (7806)
Artificial intelligence (145)
Autoimmune disease (10)
Automation (4)
Bankruptcy (120)
Best Places to Work (7185)
BIOSECURE Act (16)
Biosimilars (60)
Biotechnology (91)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (268)
Cancer (2087)
Cardiovascular disease (65)
Career advice (540)
Career pathing (10)
CAR-T (133)
Cell therapy (318)
Cervical cancer (20)
Clinical research (40029)
Collaboration (498)
Compensation (145)
Complete response letters (10)
COVID-19 (1683)
CRISPR (21)
C-suite (122)
Cystic fibrosis (45)
Data (1232)
Decentralized trials (2)
Denatured (3)
Depression (6)
Diabetes (94)
Diagnostics (4301)
Digital health (8)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (62)
Drug pricing (59)
Drug shortages (8)
Duchenne muscular dystrophy (28)
Earnings (29145)
Editorial (14)
Employer branding (6)
Employer resources (51)
Events (54538)
Executive appointments (333)
FDA (8423)
Featured Employer (16)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (442)
Gene editing (41)
Generative AI (9)
Gene therapy (126)
GLP-1 (256)
Government (3265)
Grass and pollen (1)
Guidances (23)
Healthcare (12130)
Huntington's disease (3)
IgA nephropathy (6)
Immunology and inflammation (53)
Indications (16)
Infectious disease (1751)
Inflammatory bowel disease (68)
Inflation Reduction Act (4)
Influenza (23)
Intellectual property (44)
Interviews (91)
IPO (7320)
IRA (29)
Job creations (1383)
Job search strategy (485)
Kidney cancer (10)
Labor market (10)
Layoffs (201)
Leadership (2)
Legal (3017)
Liver cancer (75)
Lung cancer (311)
Lymphoma (125)
Machine learning (2)
Management (18)
Manufacturing (125)
MASH (27)
Medical device (4786)
Medtech (4786)
Mergers & acquisitions (7376)
Metabolic disorders (211)
Multiple sclerosis (30)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (4)
Neuroscience (903)
NextGen: Class of 2025 (4055)
Non-profit (4018)
Northern California (1301)
Now hiring (8)
Obesity (93)
Opinion (114)
Ovarian cancer (75)
Pain (40)
Pancreatic cancer (78)
Parkinson's disease (45)
Partnered (12)
Patents (94)
Patient recruitment (64)
Peanut (13)
People (30956)
Pharmaceutical (23)
Pharmacy benefit managers (9)
Phase I (13991)
Phase II (17497)
Phase III (12495)
Pipeline (589)
Podcasts (23)
Policy (81)
Postmarket research (1493)
Preclinical (6114)
Press Release (30)
Prostate cancer (97)
Psychedelics (14)
Radiopharmaceuticals (242)
Rare diseases (169)
Real estate (2597)
Recruiting (23)
Regulatory (11586)
Reports (17)
Research institute (2163)
Resumes & cover letters (76)
Rett syndrome (1)
RNA editing (2)
RSV (18)
Schizophrenia (27)
Series A (67)
Series B (34)
Service/supplier (1)
Sickle cell disease (30)
Southern California (1050)
Special edition (5)
Spinal muscular atrophy (61)
Sponsored (12)
Startups (1987)
State (2)
Stomach cancer (16)
Supply chain (26)
The Weekly (20)
United States (11215)
Vaccines (405)
Venture capitalists (17)
Webinars (4)
Weight loss (47)
Women's health (19)
Worklife (4)
Date
Today (67)
Last 7 days (362)
Last 30 days (1390)
Last 365 days (18785)
2025 (4212)
2024 (19634)
2023 (22208)
2022 (29371)
2021 (31434)
2020 (30364)
2019 (27319)
2018 (20252)
2017 (16965)
2016 (16755)
2015 (19413)
2014 (14716)
2013 (12068)
2012 (12594)
2011 (13150)
2010 (11753)
Location
Africa (413)
Alabama (38)
Alaska (4)
Arizona (101)
Arkansas (8)
Asia (23587)
Australia (4344)
California (2807)
Canada (994)
China (367)
Colorado (127)
Connecticut (140)
Delaware (93)
Europe (47169)
Florida (420)
Georgia (90)
Idaho (30)
Illinois (300)
India (16)
Indiana (152)
Iowa (5)
Japan (86)
Kansas (44)
Kentucky (19)
Louisiana (2)
Maine (12)
Maryland (544)
Massachusetts (2044)
Michigan (60)
Minnesota (150)
Mississippi (2)
Missouri (59)
Montana (23)
Nebraska (12)
Nevada (28)
New Hampshire (47)
New Jersey (979)
New Mexico (19)
New York (962)
North Carolina (389)
North Dakota (4)
Northern California (1301)
Ohio (93)
Oklahoma (7)
Oregon (14)
Pennsylvania (566)
Puerto Rico (4)
Rhode Island (11)
South America (511)
South Carolina (10)
South Dakota (1)
Southern California (1050)
Tennessee (53)
Texas (552)
Utah (73)
Virginia (71)
Washington D.C. (44)
Washington State (341)
West Virginia (2)
Wisconsin (35)
359,264 Results for "nih nci national cancer institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
Chimeron Bio, a Philadelphia -headquartered biotech company, has received a 2024 National Institutes of Health’s Small Business Innovation Research Innovative Concept Award through the National Cancer Institute.
April 16, 2024
·
1 min read
Press Releases
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
March 27, 2025
·
2 min read
Pharm Country
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc. announced that it has been awarded a Small Business Innovation Research Fast-Track grant from the National Cancer Institute of the National Institutes of Health to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer.
June 14, 2024
·
2 min read
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Business
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced a strategic collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health.
June 4, 2024
·
5 min read
Press Releases
SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI)
September 18, 2024
·
2 min read
Business
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
LIXTE Biotechnology Holdings, Inc. ( Nasdaq: LIXT and LIXTW ) (“LIXTE” or the “Company”) today announced the signing of an exclusive patent license agreement with the National Institute of Neurological Disorders and Stroke (NINDS) and National Cancer Institute (NCI), each a component of the National Institute of Health (NIH).
February 26, 2024
·
4 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Business
ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research
ATCC will continue to support the National Cancer Institute’s (NCI) mission to prevent cancer and the Division of Cancer Epidemiology and Genetics (DCEG) Biospecimen Activity and Assay Support (BAAS) program.
March 19, 2024
·
3 min read
Press Releases
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
January 9, 2025
·
2 min read
1 of 35,927
Next
